Хлебные крошки
- Главная
-
Аналитика
-
Акции
Акции внутренные
Simulations Plus, Inc. SLP
$41.57
-$0.71 (-1.71%)
На 18:00, 12 мая 2023
Ранг: 2
Ключевые показатели
-
Marketcap
841270626.00000000
-
week52high
67.59
-
week52low
32.58
-
Revenue
53906000
-
P/E TTM
79
-
Beta
0.53633200
-
EPS
0.50000000
-
Last Dividend
0.24000000
-
Next Earnings Date
04 июл 2023 г. в 10:59
Описание компании
Simulations Plus, Inc. develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. It operates through four segments: Simulations Plus, Cognigen, DILIsym, and Lixoft. The company offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products. It also provides products based on mechanistic and mathematical models, such as DILIsym, a quantitative systems pharmacology software; NAFLDsym; IPFsym; RENAsym; and MITOsym. In addition, the company provides Absorption, Distribution, Metabolism, Excretion, and Toxicity Predictor for chemistry-based computer program that takes molecular structures as inputs and predicts their properties; and MedChem Designer, as well as modeling and simulation products comprising MonolixSuite and PKPlus. Further, it provides population modeling and simulation contract research services; training and consulting services designed to accelerate pharmacometrics studies; and clinical-pharmacology-based consulting services in support of regulatory submissions. The company serves pharmaceutical, biotechnology, agrochemical, cosmetics, and food companies, as well as academic and regulatory agencies. Simulations Plus, Inc. was incorporated in 1996 and is headquartered in Lancaster, California.
Рекомендации
аналитиков
Рекомендации аналитиков
| Grading company | New grade | Previous grade | Recommendation date |
|---|---|---|---|
| Craig-Hallum | Buy | Buy | 07 июл 2022 г. |
| Craig-Hallum | Buy | Hold | 26 окт 2021 г. |
| Raymond James | Outperform | Outperform | 13 июл 2021 г. |
| Craig-Hallum | Hold | Buy | 12 янв 2021 г. |
| Raymond James | Outperform | 16 окт 2020 г. | |
| Raymond James | Outperform | Outperform | 29 авг 2022 г. |
Свежие комментарии
Свежие комментарии
Оставьте свой голос
Оставьте свой голос
Анонимное голосование
Будет ли рост российского рынка к концу года?
-
Да
87% -
Нет
12%
Проголосовал 8 человек
Новостная лента
компании
Insider Summary
Insider Summary
| Reporting Name | Acquistion/Disposition | Owned | Transacted | Transaction Date |
|---|---|---|---|---|
| WEINER DANIEL L | A | 6383 | 729 | 01 февр 2023 г. |
| LaVange Lisa | A | 5889 | 729 | 01 февр 2023 г. |
| Paglia John Kenneth | A | 3125 | 729 | 01 февр 2023 г. |
| WOLTOSZ WALTER S | A | 3935739 | 729 | 01 февр 2023 г. |
| Evans Sharlene | A | 2509 | 729 | 01 февр 2023 г. |
| WOLTOSZ WALTER S | D | 3935010 | 200 | 30 янв 2023 г. |
| WOLTOSZ WALTER S | D | 3935210 | 2058 | 30 янв 2023 г. |
| WOLTOSZ WALTER S | D | 3937268 | 87 | 27 янв 2023 г. |
| WOLTOSZ WALTER S | D | 3937355 | 17655 | 27 янв 2023 г. |
| WOLTOSZ WALTER S | D | 3955010 | 1748 | 28 дек 2022 г. |
Новостная лента
Simulations Plus: Overhyped With No Growth Left
Seeking Alpha
02 мая 2023 г. в 12:38
Simulations Plus, Inc. is a company that develops software for drug discovery and development using artificial intelligence and machine learning technology. SLP has seen what was very impressive growth begin to quickly slow.
4 Low-Beta Tech Stocks to Hedge Against Market Uncertainty
Zacks Investment Research
19 апр 2023 г. в 12:10
Investors can consider adding four low-beta tech stocks like TEAM, ZS, SLP and ASUR in their portfolios to hedge against a highly-volatile market.
Can Simulations Plus (SLP) Climb 53.66% to Reach the Level Wall Street Analysts Expect?
Zacks Investment Research
07 апр 2023 г. в 11:29
The mean of analysts' price targets for Simulations Plus (SLP) points to a 53.7% upside in the stock. While this highly sought-after metric has not proven reasonably effective, strong agreement among analysts in raising earnings estimates does indicate an upside in the stock.
Simulations Plus (SLP) Q2 Earnings Beat, Revenues Up Y/Y
Zacks Investment Research
06 апр 2023 г. в 09:11
Simulations Plus' (SLP) Q2 results are driven by higher revenues in Software and Services business segments.
Simulations Plus, Inc. (SLP) Q2 2023 Earnings Call Transcript
Seeking Alpha
05 апр 2023 г. в 20:09
Simulations Plus, Inc. (NASDAQ:SLP ) Q2 2023 Earnings Conference Call March 5, 2023 5:00 PM ET Company Participants Brian Siegel - Hayden IR Shawn O'Connor - Chief Executive Officer Will Frederick - Chief Financial Officer Conference Call Participants François Brisebois - Oppenheimer Matt Hewitt - Craig-Hallum Mitra Ramgopal - Sidoti Dane Leone - Raymond James Operator Greetings, and welcome to the Simulations Plus Second Quarter Fiscal 2023 Financial Results Conference Call. At this time, all participants are in a listen-only mode.